Gosebruch Henry O's Form 4 filing
AbbVie Inc. (ABBV) · filed May 18, 2022
- Accession no.
- 0001179110-22-003076
- Filed
- May 18, 2022
- Trade date
- May 16, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $13.0M. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001179110-22-003108 (May 20, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gosebruch Henry OCIK 0001659625 | Officer (EVP, Chief Strategy Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2022 | Common Stock, $0.01 par value | MOption exerciseAcquired | +83,960 | $54.86 | +$4,606,045.6 | 100,583 | Direct | |
| May 16, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −83,960 | $155.00 | −$13,013,800 | 16,623 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2022 | Common Stock | MOption exerciseDisposed | −83,960 | $54.86 | −$4,606,045.6 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The option exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).